Subsequently, several studies revealed the immunological property of AZA increasing the response of tumor-specific CD8+ T-cells upregulating silenced tumor antigens, HLA, and costimulatory molecules on the leukemic cells [31]. This evidence concerns the gene CD276 and neoplasm.